NR Nicotinamide Riboside (300mg, 60 caps)
Oral NAD+ precursor with human trial data. Third-party tested. The thing the IV bag should have been.
Secure checkout · Tax calculated at checkout
Product details
Oral NAD+ precursor with human trial data. Third-party tested. The thing the IV bag should have been.
How Codex curates products
Every product passes three checks before it reaches you.
Brand discovery
We surface brands operators and coaches are already buying — never paid placement.
Wellness review
Each SKU is scored against our charter: ingredient quality, evidence, claims, sourcing.
Operator-tested
Coaches and studios in our network try it on real clients before we recommend it.
Learn more
Guide
The Wellness Edit: What We’re Reading This Week (2026-07-07)
From the longevity clinic boom to the nuanced reality of AI coaching, here are the essential wellness industry reads you missed this week, curated by Codex.
Guide
Codex Reads: Our Editorial Picks for July 4, 2026
From the speculative biotech of aging to the business of boutique fitness, here's what the Codex editorial team is reading and debating this week.
Guide
NAD+ IV drips: €800 for a placebo with a needle
The longevity clinic's favourite upsell. The molecule is real. The IV route is mostly theatre, and the people selling it know it.
Vetted under the Codex charter
We only stock products that pass our ingredient, evidence and sourcing review. If a SKU stops meeting the bar, it's delisted — full stop.